【ChiCTR1900027348】研究伦理审批文件无法正常显示，请重新上传。 Treatment of onychomycosis with fractional CO2 laser combined with topical anti fungul-A multicenter randomized controlled trial
ChiCTR1900027348
结束
/
/
/
2019-11-09
/
/
Onychomycosis
研究伦理审批文件无法正常显示，请重新上传。 Treatment of onychomycosis with fractional CO2 laser combined with topical anti fungul-A multicenter randomized controlled trial
Treatment of onychomycosis with fractional CO2 laser combined with topical anti fungul-A multicenter randomized controlled study
To statistically compare the efficacy and safety of Fractional CO2 laser combined with topical antifungal and only topical antifungal in multiple centers.
随机平行对照
其它
Blocked randomized sequence was generated by SAS 9.4 statistical software and with a 1:1 allocation between two groups. It was done by a statistician who was not involved in the trial.
Not stated
上海申康医院发展项目
/
80
/
2016-12-01
2019-06-30
/
(1) aged 18-75 years; (2) unbiased to gender; (3) diagnosis confirmed through fungal test (direct microscopic using KOH and culture in Sabouraud dextrose agar medium, at 28 degree C for 7 days); (4) signed a written consent to be enrolled in the study.；
请登录查看(1) if they had systemic treatment of the disease 48 weeks prior to the enrollment in our survey; (2) if they did nail dying; (3) if they are under photosensitive drugs; (4) pregnant women; (5) who have sub-ungula hemorrhage or sub-ungula nevus; (6) patients with combined other diseases such as psoriasis, Wilsons Lichen, atopic dermatitis that might cause nail deformity.；
请登录查看上海申康医院发展项目
/
上海申康医院发展项目的其他临床试验
上海同济医院的其他临床试验
- 研究伦理审批文件无法正常显示，请重新上传。 Treatment of onychomycosis with fractional CO2 laser combined with topical anti fungul-A multicenter randomized controlled trial
- 急性亚极量平板运动改善高肾素型高血压动态血压和血管顺应性的临床研究
- 不同麻醉药物对腹腔镜患者术后认知功能障碍及炎性因子的影响
- Ph样急性淋巴细胞白血病JAK,ABL及TF通路异常的检测与靶向治疗
- 阿罗洛尔联合钙离子拮抗剂治疗原发性高血压的有效性与安全性：1年随访
- 阻塞型睡眠呼吸暂停低通气综合征患者咳嗽敏感性变化及其意义
最新临床资讯
-
Nat Rev Clin Oncol｜AI赋能肿瘤临床试验：从流程优化到证据生成的全景透视
智药邦2026-08-12
-
康臣药业1类新药糖肾方“芪箭颗粒”获NMPA临床研究许可
康臣药业2026-08-12
-
璎黎药业2026-08-12
-
幂方健康基金2026-08-12
-
细胞与基因治疗领域2026-08-12
-
云南白药2026-08-12
-
细胞治疗前沿2026-08-12
-
广州达博生物制品有限公司2026-08-12
-
医药笔记2026-08-12
-
医药笔记2026-08-12
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 27
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 38
-
摩熵咨询 34 18
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29